These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32589896)

  • 1. Reply to: Correspondence relating to "SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19".
    Wang Y; Lu F; Zhao J
    J Hepatol; 2020 Oct; 73(4):996-998. PubMed ID: 32589896
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 another kind of liver aggressor, how does it do that?
    Lozano-Sepulveda SA; Galan-Huerta K; Martínez-Acuña N; Arellanos-Soto D; Rivas-Estilla AM
    Ann Hepatol; 2020; 19(6):592-596. PubMed ID: 32858226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and the liver: What do we know after six months of the pandemic?
    Fierro NA
    Ann Hepatol; 2020; 19(6):590-591. PubMed ID: 32956871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.
    Ji D; Xu J; Qin E; Zhang D; Cheng G; Wang Y; Lau G
    J Hepatol; 2020 Sep; 73(3):718-719. PubMed ID: 32387073
    [No Abstract]   [Full Text] [Related]  

  • 6. [The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):217-221. PubMed ID: 32306655
    [No Abstract]   [Full Text] [Related]  

  • 7. Digestive and Liver Diseases and the COVID-19 Pandemic.
    de Franchis R
    Dig Liver Dis; 2020 Aug; 52(8):799. PubMed ID: 32713475
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to: "Liver tests abnormalities in COVID-19: trick or treat?".
    Cai Q; Xu L; Chen J
    J Hepatol; 2020 Nov; 73(5):1277-1278. PubMed ID: 32634547
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 and the liver: little cause for concern.
    Bangash MN; Patel J; Parekh D
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):529-530. PubMed ID: 32203680
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical insight into the involvement of gut and liver by COVID-19.
    Abbas Z; Zaheer R
    J Pak Med Assoc; 2020 Jun; 70(6):952-953. PubMed ID: 32810083
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastrointestinal and liver involvement in patients with COVID-19.
    Barrera FJ; González-González JG; Rodríguez-Gutiérrez R
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):799. PubMed ID: 32818458
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID 19 and the Liver.
    Shukla A; Mohanka R
    J Assoc Physicians India; 2020 Nov; 68(11):11-12. PubMed ID: 33187029
    [No Abstract]   [Full Text] [Related]  

  • 13. Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy.
    Di Giorgio A; Nicastro E; Speziani C; De Giorgio M; Pasulo L; Magro B; Fagiuoli S; D' Antiga L
    J Hepatol; 2020 Sep; 73(3):702-705. PubMed ID: 32413378
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to: "Clinical characteristics of COVID-19 patients with abnormal liver tests".
    Cai Q; Chen J
    J Hepatol; 2020 Sep; 73(3):713-714. PubMed ID: 32387074
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to correspondence: Vaginal delivery in a woman infected with SARS-CoV-2 - The first case reported in Portugal.
    Carbone IF; D'Ambrosi F; Saccone G
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():613. PubMed ID: 32653231
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastrointestinal and liver involvement in patients with COVID-19 - Authors' reply.
    Qiu Y; He JS; Tan JY; Lin SN; Mao R
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):799-800. PubMed ID: 32818457
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19: An Overview of Worldwide Recommendations for Management of Patients With Liver Diseases or Liver Transplantation.
    Perazzo H; Piedade J; Castro R; Pinto L; Veloso VG; Grinsztejn B; Pereira G; Fernandes FF
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2381-2384.e10. PubMed ID: 32407967
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply (by Kevin Welch) to Zara Patel Correspondence.
    Welch KC
    Int Forum Allergy Rhinol; 2020 May; 10(5):589-590. PubMed ID: 32297406
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications.
    Hajifathalian K; Krisko T; Mehta A; Kumar S; Schwartz R; Fortune B; Sharaiha RZ;
    Gastroenterology; 2020 Sep; 159(3):1137-1140.e2. PubMed ID: 32389667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.